Literature DB >> 10904396

[Estimated number of HIV-infected individuals aged 15-49 years in Brazil, 1998].

C L Szwarcwald1, E A Castilho.   

Abstract

This study estimates the number of HIV-infected individuals from 15 to 49 years of age in Brazil in 1998 based on sentinel population studies in pregnant women, with a selection bias in the sample. A principal components procedure was used to group 44 counties in homogeneous 13 clusters. Two indicators were constructed for each cluster: a) the logarithm of the accumulated AIDS incidence rate among women from 15 to 34 years of age (1996) and b) the logarithm of the growth ratio for the mean AIDS incidence rate for women from 15 to 34 years of age for the period from 1990-1992 to 1993-1996. Taking the log of the proportion of HIV-infected pregnant women as the dependent variable and the two above-mentioned indicators as the independent variables, a regression line was fitted to the aggregate data. Estimation of the model's parameters allowed us to calculate the proportion of infected individuals by macro-region, by age (15-34 and 35-49 years) and gender. The point estimate was 536 thousand HIV-infected adults with a 68% CI (470.689 - 603.305).

Entities:  

Mesh:

Year:  2000        PMID: 10904396

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  4 in total

1.  Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil.

Authors:  Antonio G Pacheco; Valeria Saraceni; Suely H Tuboi; Lilian M Lauria; Lawrence H Moulton; José Cláudio Faulhaber; Bonnie King; Jonathan E Golub; Betina Durovni; Solange Cavalcante; Lee H Harrison; Richard E Chaisson; Mauro Schechter
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-07       Impact factor: 2.205

2.  Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil.

Authors:  Ester C Sabino; Thelma T Gonçalez; Anna Bárbara Carneiro-Proietti; Moussa Sarr; João Eduardo Ferreira; Divaldo A Sampaio; Nanci A Salles; David J Wright; Brian Custer; Michael Busch
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

3.  Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

Authors:  Amy S Nunn; Elize M Fonseca; Francisco I Bastos; Sofia Gruskin; Joshua A Salomon
Journal:  PLoS Med       Date:  2007-11-13       Impact factor: 11.069

4.  Transitioning from antenatal surveillance surveys to routine HIV testing: a turning point in the mother-to-child transmission prevention programme for HIV surveillance in Brazil.

Authors:  Gerson Fernando Mendes Pereira; Meritxell Sabidó; Alessandro Caruso; Adele Schwartz Benzaken
Journal:  BMC Infect Dis       Date:  2017-07-05       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.